532649

Nectar Lifesciences Ltd

BSE
Last Traded Price
₹12.47 -0.64 (-4.88%)
Open
₹13.11
High
₹13.11
Low
₹12.46
Prev Close
₹13.11
Industry
Healthcare
Market Cap
242.24 Cr

Price Chart

Loading chart data...
Data delayed by up to 5 minutes. Not live.

Filing History

Recent corporate announcements and filings for 532649

Governance Neutral
2026-08-22 14:34
- Nectar Lifesciences Ltd. announced its 31st Annual General Meeting (AGM) for the financial year 2025-26. - The AGM is scheduled for Friday, September 18, 2026, at 11:00 A.M. IST, to be held via video conference/other audio-visual means. - Remote e-voting will commence on September 15, 2026 (9:00 A.M. IST) and conclude on September 17, 2026 (5:00 P.M. IST). - The Annual Report 2025-26 and AGM Notice are available on the company's website and stock exchange websites.
Business Update Neutral
2026-08-15 11:40
- Nectar Lifesciences Ltd. approved changing its corporate office from Plot No. 110 to Godrej Eternia, Plot No. 70, Industrial Area, Phase-1, Chandigarh. - The change is effective from September 15, 2026.
Financials Negative
2026-08-14 20:50
CRITICAL RED FLAG DETECTED
- Q1 FY27 Consolidated Total Income ₹336.20 Lakhs vs ₹30.94 Lakhs (▲986.75% YoY) - EBITDA (₹2,435.20) Lakhs vs ₹22.21 Lakhs (▼11064.30% YoY) - PAT (₹1,571.87) Lakhs vs ₹8.81 Lakhs (▼17887.28% YoY) - EBITDA Margin -724.33% vs 71.79% (▼79612 bps) - The auditors issued a qualified opinion on consolidated financial results as interim financial information of a subsidiary was not reviewed by their auditors. - Dr. Gunmala Suri was appointed as an Additional Non-Executive Non-Independent Director. - The 31st Annual General Meeting (AGM) is scheduled for September 18, 2026.
Governance Neutral
2026-08-10 20:46
- Notice of Board Meeting of Nectar Lifesciences Ltd. to be held on August 14, 2026. - The Board will consider and approve the Unaudited Financial Results for the quarter ended June 30, 2026.
Governance Negative
2026-08-06 18:19
CRITICAL RED FLAG DETECTED
- Dr. Surulichamy Senthilkumar has resigned as a Non-Executive Non-Independent Director of Nectar Lifesciences Limited, effective from the closing hours of August 06, 2026, due to pre-occupations and other personal reasons.
Business Update Positive
2026-08-04 23:45
- Nectar Lifesciences Ltd. sold the leasehold rights and plant & machinery of its inoperative, non-core unit, Narbada Industries, in Jammu. - The total consideration received is INR 9,60,00,000/- for leasehold rights and INR 1,62,00,000/- for plant & machinery. - The purchaser is M/s. Shree Balaji Cold Chain & Storage Services.
Business Update Neutral
2026-07-23 17:11
- Nectar Lifesciences Ltd. and Capnest Health Care Private Limited have mutually agreed to extend the completion date for the slump sale of the Empty Hard Gelatin Capsule business. - The new expected completion date is on or before December 31, 2026.
Routine Neutral
2026-07-11 20:39
- The Board of Directors approved the shifting of the Company's Registered Office within the local limits of Dera Bassi, Punjab. - The new registered office will be Showroom no. 8, First Floor, Patiala Complex, Barwala Road, Dera Bassi. - The change is effective from July 15, 2026. - The Company stated that this change does not affect its operations or any other statutory registrations.
Routine Neutral
2026-06-24 18:30
- Trading window for designated persons and their immediate relatives to close from July 01, 2026. - Closure is until 48 hours after financial results for the quarter ended June 30, 2026, are declared, as per SEBI regulations.

Unlock Full History

Log in to view all historical filings for 532649 and get instant Telegram alerts when new announcements drop.

Login with Telegram